NL9000917A - Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. - Google Patents

Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. Download PDF

Info

Publication number
NL9000917A
NL9000917A NL9000917A NL9000917A NL9000917A NL 9000917 A NL9000917 A NL 9000917A NL 9000917 A NL9000917 A NL 9000917A NL 9000917 A NL9000917 A NL 9000917A NL 9000917 A NL9000917 A NL 9000917A
Authority
NL
Netherlands
Prior art keywords
furin
enzyme
protein
fragment
derivative
Prior art date
Application number
NL9000917A
Other languages
English (en)
Dutch (nl)
Original Assignee
Holland Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26646599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL9000917(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NL8902651A external-priority patent/NL8902651A/nl
Application filed by Holland Biotechnology filed Critical Holland Biotechnology
Priority to NL9000917A priority Critical patent/NL9000917A/nl
Priority to EP90915837A priority patent/EP0497828B2/de
Priority to CA002069929A priority patent/CA2069929C/en
Priority to DK90915837T priority patent/DK0497828T4/da
Priority to EP98200913A priority patent/EP0885956A1/de
Priority to AT90915837T priority patent/ATE147437T1/de
Priority to EP95202272A priority patent/EP0693286A1/de
Priority to PCT/NL1990/000151 priority patent/WO1991006314A2/en
Priority to AU66132/90A priority patent/AU6613290A/en
Priority to ES90915837T priority patent/ES2099714T5/es
Priority to US07/849,420 priority patent/US5989856A/en
Priority to DE69029663T priority patent/DE69029663T3/de
Priority to JP51489590A priority patent/JP3191111B2/ja
Publication of NL9000917A publication Critical patent/NL9000917A/nl
Priority to NO19921611A priority patent/NO311895B1/no
Priority to FI921847A priority patent/FI105348B/fi
Priority to GR970400685T priority patent/GR3023013T3/el
Priority to US08/865,203 priority patent/US5935815A/en
Priority to US08/955,424 priority patent/US6274365B1/en
Priority to US09/253,854 priority patent/US6132717A/en
Priority to JP2000381776A priority patent/JP3270760B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/62—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from Aspergillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL9000917A 1989-10-25 1990-04-18 Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. NL9000917A (nl)

Priority Applications (20)

Application Number Priority Date Filing Date Title
NL9000917A NL9000917A (nl) 1989-10-25 1990-04-18 Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
DE69029663T DE69029663T3 (de) 1989-10-25 1990-10-12 Verfahren zur endoproteolytischen bearbeitung von (vorläufer)proteinen und zur (mikro)biologischen herstellung
JP51489590A JP3191111B2 (ja) 1989-10-25 1990-10-12 （前駆体）タンパクのエンドタンパク分解的プロセシングのための方法
ES90915837T ES2099714T5 (es) 1989-10-25 1990-10-12 Procedimiento de tratamiento endoproteolitico de las proteinas (precursores) y de produccion microbiologica de proteinas.
US07/849,420 US5989856A (en) 1989-10-25 1990-10-12 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
DK90915837T DK0497828T4 (da) 1989-10-25 1990-10-12 Fremgangsmåde til endoproteolytisk behandling af (forstadie)proteiner og til (mikro)biologisk produktion af proteiner.
EP98200913A EP0885956A1 (de) 1989-10-25 1990-10-12 Pharmazeutische Zusammensetzungen mit endoproteolytischer Aktivität, Verfahren zur endoproteolytischen Bearbeitung von (vorläufer)Proteinen und zur (Mikro)biologischen Herstellung von Proteinen
AT90915837T ATE147437T1 (de) 1989-10-25 1990-10-12 Verfahren zur endoproteolytischen bearbeitung von (vorläufer)proteinen und zur (mikro)biologischen herstellung
EP95202272A EP0693286A1 (de) 1989-10-25 1990-10-12 Furin enthaltende pharmazeutische Zusammensetzung
PCT/NL1990/000151 WO1991006314A2 (en) 1989-10-25 1990-10-12 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
AU66132/90A AU6613290A (en) 1989-10-25 1990-10-12 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
EP90915837A EP0497828B2 (de) 1989-10-25 1990-10-12 Verfahren zur endoproteolytischen bearbeitung von (vorläufer)proteinen und zur (mikro)biologischen herstellung
CA002069929A CA2069929C (en) 1989-10-25 1990-10-12 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
FI921847A FI105348B (fi) 1989-10-25 1992-04-24 Menetelmä proteiinien käsittelemiseksi endoproteolyyttisesti sekä menetelmä proteiinien valmistamiseksi (mikro)biologisesti
NO19921611A NO311895B1 (no) 1989-10-25 1992-04-24 Anvendelse av furin eller furinlignende enzym for spalting av et protein, fremgangsmåte for mikrobiologisk fremstilling av etprotein og pattedyrcelle som omfatter DNA som koder for enzymet
GR970400685T GR3023013T3 (en) 1989-10-25 1997-04-02 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
US08/865,203 US5935815A (en) 1989-10-25 1997-05-29 Process for micro biological production of proteins
US08/955,424 US6274365B1 (en) 1989-10-25 1997-10-22 Pharmaceutical composition having an endoproteolytic activity
US09/253,854 US6132717A (en) 1989-10-25 1999-02-19 Method for treating mammals having a deficiency in endoprotease
JP2000381776A JP3270760B2 (ja) 1989-10-25 2000-12-15 フリンによるタンパクの微生物的生産方法及びその生産のための細胞

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NL8902651 1989-10-25
NL8902651A NL8902651A (nl) 1989-10-25 1989-10-25 Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van eiwitten.
NL9000917 1990-04-18
NL9000917A NL9000917A (nl) 1989-10-25 1990-04-18 Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.

Publications (1)

Publication Number Publication Date
NL9000917A true NL9000917A (nl) 1991-05-16

Family

ID=26646599

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9000917A NL9000917A (nl) 1989-10-25 1990-04-18 Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.

Country Status (13)

Country Link
US (1) US5989856A (de)
EP (3) EP0885956A1 (de)
JP (2) JP3191111B2 (de)
AT (1) ATE147437T1 (de)
AU (1) AU6613290A (de)
CA (1) CA2069929C (de)
DE (1) DE69029663T3 (de)
DK (1) DK0497828T4 (de)
ES (1) ES2099714T5 (de)
FI (1) FI105348B (de)
GR (1) GR3023013T3 (de)
NL (1) NL9000917A (de)
WO (1) WO1991006314A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935815A (en) * 1989-10-25 1999-08-10 Katholieke Universiteit Leuven Process for micro biological production of proteins
JP4236698B2 (ja) * 1990-11-26 2009-03-11 ジェネティックス インスティチュート，リミテッド ライアビリティ カンパニー 宿主細胞でのｐａｃｅの発現およびその使用法
US6348327B1 (en) 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
DK52293D0 (de) * 1993-05-05 1993-05-05 Novo Nordisk As
US6005077A (en) * 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
AT404838B (de) * 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
US6596526B1 (en) 2000-06-09 2003-07-22 Baxter Aktiengesellschaft Furin polypeptides with improved characteristics
WO2005103245A1 (en) * 2004-04-23 2005-11-03 Novozymes A/S Method for obtaining mature protease by enzymatic digestion
US8343748B2 (en) * 2007-05-22 2013-01-01 Baxter International Inc. Preparative purification process for human furin
KR101818411B1 (ko) 2007-12-27 2018-01-12 박스알타 인코퍼레이티드 세포 배양 방법
DK2240578T3 (da) 2007-12-31 2019-06-17 Baxalta GmbH I alt væsentligt dyreproteinfrit rekombinant furin og fremgangsmåder til fremstilling af samme
US20130149295A1 (en) 2010-05-12 2013-06-13 Martine Cohen-Solal Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease
BR112013030880B1 (pt) 2011-06-02 2022-04-12 Takeda Pharmaceutical Company Limited Composição aquosa estabilizada de furina recombinante

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246709A1 (de) * 1986-05-20 1987-11-25 Stichting Katholieke Universiteit Rekombinantes DNS, komplementäre DNS, Protein, Antikörper und Verfahren zum Nachweis von Tumorzellen
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells

Also Published As

Publication number Publication date
EP0497828A1 (de) 1992-08-12
ATE147437T1 (de) 1997-01-15
GR3023013T3 (en) 1997-07-30
JP3270760B2 (ja) 2002-04-02
AU6613290A (en) 1991-05-31
FI921847A0 (fi) 1992-04-24
EP0497828B1 (de) 1997-01-08
DK0497828T4 (da) 2008-02-04
DK0497828T3 (da) 1997-07-07
FI921847A (fi) 1992-04-24
WO1991006314A2 (en) 1991-05-16
FI105348B (fi) 2000-07-31
CA2069929A1 (en) 1991-04-26
ES2099714T3 (es) 1997-06-01
DE69029663T3 (de) 2008-05-21
CA2069929C (en) 2002-08-27
JP3191111B2 (ja) 2001-07-23
EP0693286A1 (de) 1996-01-24
ES2099714T5 (es) 2008-04-01
EP0497828B2 (de) 2007-10-03
JP2001238683A (ja) 2001-09-04
US5989856A (en) 1999-11-23
EP0885956A1 (de) 1998-12-23
JPH05504051A (ja) 1993-07-01
DE69029663T2 (de) 1997-09-04
WO1991006314A3 (en) 1991-09-05
DE69029663D1 (de) 1997-02-20

Similar Documents

Publication Publication Date Title
KR101304958B1 (ko) 트립신 변이체에 의한 인슐린 전구체의 절단
US6274365B1 (en) Pharmaceutical composition having an endoproteolytic activity
EP0370036B1 (de) Modifizierter faktor vii/viia
US5512459A (en) Enzymatic method for modification or recombinant polypeptides
NL9000917A (nl) Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
WO2008000445A1 (en) Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells
JPH0824579B2 (ja) ヒトウロキナーゼ
EP0966536A1 (de) Faktor x-analoge mit modifizierter proteasespaltstelle
US6348327B1 (en) Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
US20040203095A1 (en) Method for producing recombinant trypsin
DE60038312T2 (de) Faktor x-analog mit einer verbesserten fähigkeit, aktiviert zu werden
JP2851287B2 (ja) 酵素前駆体型ヒトプロテインｃの発現のためのベクターおよび化合物
CN106609266A (zh) 一种微纤溶酶原变体及通过其得到的微纤溶酶变体
Ledgerwood et al. Endoproteolytic processing of recombinant proalbumin variants by the yeast Kex2 protease
JPH06197759A (ja) ジクチオステリウムのジペプチジルアミノペプチダーゼ
CA2369973C (en) Preparation of pancreatic procarboxypeptidase b, isoforms and muteins thereof and their use
KR100441384B1 (ko) 인간 혈청 알부민-팀프-2 융합 단백질 발현시스템 및재조합 인간 혈청 알부민-팀프-2 융합 단백질
NL8902651A (nl) Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van eiwitten.
NO311895B1 (no) Anvendelse av furin eller furinlignende enzym for spalting av et protein, fremgangsmåte for mikrobiologisk fremstilling av etprotein og pattedyrcelle som omfatter DNA som koder for enzymet
Whitworth et al. Molecular cloning of Soli E2: An elastase-like serine proteinase from the imported red fire ant (Solenopsis invicta)
Hoyer et al. Production of human therapeutic proteins in transgenic animals
Kaufman et al. Factors Limiting Expression of Secreted Proteins in Mammalian Cells
US20030077811A1 (en) ADAMTS nucleic acids and proteins

Legal Events

Date Code Title Description
BV The patent application has lapsed